)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
CelLBxHealth
CelLBxHealth (CLBX) investor relations material
CelLBxHealth Q1 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 TU earnings summary11 May, 2026
Executive summary
Q1 2026 focused on organizational restructuring and cost-saving measures to align with a revised business strategy.
Headcount reduced from 44 to 39 FTEs in Q1, following a 60% reduction last year.
Annual cash operating costs reduced by over £6.6 million, with further Q2 savings of £0.1 million identified.
Cash at 31 March 2026 stood at £4.3 million, reflecting one-off restructuring costs.
Outlook and guidance
Revenue for FY 2026 expected to reach at least £2.1 million, a 50% increase over FY 2025.
Additional sales pipeline opportunities could further increase revenue guidance for the year.
Board remains confident in delivering significant growth in 2026 and beyond.
Significant events and developments
New head of sales appointed in the US to drive commercial progress.
Advanced discussions underway with a major US healthcare provider for clinical studies using the Parsortix® platform.
Final stages of a Master Services Agreement with a top ten global pharmaceutical company for Parsortix® platform use.
Sub-lease agreement completed for part of the US facility.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from CelLBxHealth
- Fundraise, restructuring, and partnerships drive CTC diagnostics growth and target 2028 profitability.CLBX
Investor Update13 Apr 2026 - Revenue doubled and losses narrowed as commercial momentum builds and cash runway extends.CLBXH2 202320 Feb 2026
- Large pharma contracts and cost controls set the stage for growth and cashflow positive trading by 2026.CLBXH1 202420 Jan 2026
- FY2025 revenue was £1.4M, with cost savings and a strong cash position driving 2026 growth.CLBXQ4 2025 TU16 Jan 2026
- Patented blood test isolates living tumor cells, enabling earlier, more precise cancer care.CLBXEmerging Growth Conference 7926 Dec 2025
- 31% revenue growth, major pharma wins, and strong pipeline with cash runway into Q1 2026.CLBXH2 202410 Nov 2025
- Revenue fell to £0.8m, but new contracts and cost controls support future growth.CLBXH1 202531 Oct 2025
- ANGLE forecasts strong revenue growth and reduced losses, with a robust cash runway into 2026.CLBXTrading Update6 Jun 2025
Next CelLBxHealth earnings date
H2 202519 Jun, 2026
CelLBxHealth
Next CelLBxHealth earnings date
H2 202519 Jun, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage